Researchers at UC San Diego used a multi-omics approach to investigate stool samples from patients with ulcerative colitis, a chronic inflammatory bowel disease. The team has identified the family of microbiome-derived enzymes driving the disease, and demonstrated a potential therapeutic solution.
Related Articles

News
52 UC San Diego Researchers Are Most Highly Cited in Their Fields
November 25, 2019
sandiegobiotech
News
Comments Off on 52 UC San Diego Researchers Are Most Highly Cited in Their Fields

News
First in the Nation: All San Diego Hospitals Now Accredited for Geriatric Emergency Care
August 18, 2022
sandiegobiotech
News, UCSD News
Comments Off on First in the Nation: All San Diego Hospitals Now Accredited for Geriatric Emergency Care
Susan Nelson, a retired schoolteacher from San Diego, never thought she’d have to call 911 for herself. “It was late at night, last November, and I was having unusual symptoms.
[…]

News
Later Hit: Does Cannabis Ease Pain, Speed Recovery in Injured Athletes?
February 1, 2022
sandiegobiotech
News, UCSD News
Comments Off on Later Hit: Does Cannabis Ease Pain, Speed Recovery in Injured Athletes?
The National Football League is funding a novel clinical trial by UC San Diego researchers to assess whether cannabis or CBD provide any post-game pain relief caused by athletic injury. Trial participants will b… […]